Sign In
Buy WLKP
Westlake Chemical Partners LP Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.430 |
| EPS actual | $0.400 |
| EPS Surprise | -6.98% |
| Revenue estimate | 522M |
| Revenue actual | 305.675M |
| Revenue Surprise | -41.44% |
| Release date | Feb 24, 2026 |
| EPS estimate | $0.379 |
| EPS actual | $0.410 |
| EPS Surprise | 8.18% |
| Revenue estimate | 313M |
| Revenue actual | 323.049M |
| Revenue Surprise | 3.21% |
| Release date | Oct 30, 2025 |
| EPS estimate | $0.430 |
| EPS actual | $0.420 |
| EPS Surprise | -2.33% |
| Revenue estimate | 303M |
| Revenue actual | 308.898M |
| Revenue Surprise | 1.95% |
| Release date | Aug 05, 2025 |
| EPS estimate | $0.444 |
| EPS actual | $0.410 |
| EPS Surprise | -7.72% |
| Revenue estimate | 301M |
| Revenue actual | 297.119M |
| Revenue Surprise | -1.29% |
Last 4 Quarters for Westlake Chemical Partners LP
Below you can see how WLKP performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 05, 2025 |
| Price on release | $22.01 |
| EPS estimate | $0.444 |
| EPS actual | $0.410 |
| EPS surprise | -7.72% |
| Date | Price |
|---|---|
| Jul 30, 2025 | $21.96 |
| Jul 31, 2025 | $22.03 |
| Aug 01, 2025 | $21.82 |
| Aug 04, 2025 | $21.80 |
| Aug 05, 2025 | $22.01 |
| Aug 06, 2025 | $21.92 |
| Aug 07, 2025 | $21.96 |
| Aug 08, 2025 | $21.95 |
| Aug 11, 2025 | $22.32 |
| 4 days before | 0.228% |
| 4 days after | 1.41% |
| On release day | -0.409% |
| Change in period | 1.64% |
| Release date | Oct 30, 2025 |
| Price on release | $18.95 |
| EPS estimate | $0.430 |
| EPS actual | $0.420 |
| EPS surprise | -2.33% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $19.87 |
| Oct 27, 2025 | $19.63 |
| Oct 28, 2025 | $19.31 |
| Oct 29, 2025 | $18.95 |
| Oct 30, 2025 | $18.95 |
| Oct 31, 2025 | $18.86 |
| Nov 03, 2025 | $18.67 |
| Nov 04, 2025 | $18.50 |
| Nov 05, 2025 | $18.66 |
| 4 days before | -4.63% |
| 4 days after | -1.53% |
| On release day | -0.475% |
| Change in period | -6.09% |
| Release date | Feb 24, 2026 |
| Price on release | $22.08 |
| EPS estimate | $0.379 |
| EPS actual | $0.410 |
| EPS surprise | 8.18% |
| Date | Price |
|---|---|
| Feb 18, 2026 | $21.34 |
| Feb 19, 2026 | $20.94 |
| Feb 20, 2026 | $21.21 |
| Feb 23, 2026 | $21.24 |
| Feb 24, 2026 | $22.08 |
| Feb 25, 2026 | $22.01 |
| Feb 26, 2026 | $21.86 |
| Feb 27, 2026 | $22.02 |
| Mar 02, 2026 | $22.19 |
| 4 days before | 3.47% |
| 4 days after | 0.498% |
| On release day | -0.317% |
| Change in period | 3.98% |
| Release date | May 05, 2026 |
| Price on release | $22.57 |
| EPS estimate | $0.430 |
| EPS actual | $0.400 |
| EPS surprise | -6.98% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $22.86 |
| Apr 30, 2026 | $23.05 |
| May 01, 2026 | $22.99 |
| May 04, 2026 | $22.67 |
| May 05, 2026 | $22.57 |
| May 06, 2026 | $23.45 |
| May 07, 2026 | $23.20 |
| May 08, 2026 | $23.28 |
| May 11, 2026 | $23.72 |
| 4 days before | -1.27% |
| 4 days after | 5.10% |
| On release day | 3.90% |
| Change in period | 3.76% |
Westlake Chemical Partners LP Earnings Call Transcript Summary of Q1 2026
Westlake Chemical Partners reported Q1 2026 results: Partnership net income was $14 million ($0.40/unit) and consolidated net income was $82 million on consolidated sales of $306 million. Distributable cash flow was $18 million ($0.51/unit). The partnership declared a quarterly distribution of $0.4714/unit (47th consecutive quarterly distribution since the 2014 IPO) and reported a trailing 12-month coverage ratio that improved to 1.0x (operating surplus improved by $1M). Balance sheet metrics remain conservative: consolidated cash with Westlake totaled $81 million and consolidated long-term debt was $400 million, yielding a consolidated leverage ratio of approximately 1x. OpCo capex was $6 million in the quarter and there are no planned turnarounds for 2026. Management highlighted near-term market tailwinds from disrupted global supply (Middle East conflict) that have raised North American ethylene prices; while ~95% of OpCo ethylene is sold to Westlake at a fixed $0.10/lb margin, the ~5% sold to third parties is capturing higher margins. Management will evaluate growth via four levers (increasing OpCo ownership, acquisitions, organic expansions, or negotiating a higher fixed margin). A CFO transition was announced: Jon Baksht will join June 15 as CFO; current CFO Steve Bender will transition to Special Adviser.
